Trade, Investment, Innovation and their Impact on Access to Medicines: An Asian Perspective: 22 (Cambridge International Trade and Economic Law, Series Number 22)
Cambridge University Press, 12/20/2018
EAN 9781107421035, ISBN10: 1107421039
Paperback, 486 pages, 22.9 x 15.2 x 2.8 cm
Language: English
The last two decades have seen great economic change in Asia and this has impacted upon the vexed question of access to affordable healthcare and medicines in many Asian states. In this book Locknie Hsu examines the issue of access to medicines in Asia from a fresh perspective which embraces trade and investment law, innovation, intellectual property law, competition policy and public health issues. Hsu explores the key evolving legal issues in these areas, including ASEAN integration, free trade agreement negotiations (such as those for the TPP), bilateral investment agreements and significant court decisions. The book goes on to present proposals for steps to be taken in addressing access to medicines in Asia and will be useful to academic researchers, regulators, law-makers and global organizations involved in the issues surrounding access to affordable healthcare and medicines.
Foreword Sundaresh Menon
Preface and acknowledgements
1. Economic integration, Asia and medicines
2. Access to medicines, innovation and the debate at the multilateral level
3. Trade, investment and medicines
the existing legal and policy construct
4. Treaties in Asia
embedded risks and lessons from disputes elsewhere
5. The importance of exceptions and flexibilities
6. Innovation and competition
7. Setting new directions
the need for innovative legal and policy solutions
8. What next?